X0HQ3R8
Insertion Vagus Nerve to New Technology Group 8 with Neurostimulator Lead with Paired Stimulation System, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 0 Nervous System |
| Operation | H Insertion |
| Body Part | Q Vagus Nerve |
| Approach | 3 Percutaneous |
| Device | R Neurostimulator Lead with Paired Stimulation System |
| Qualifier | 8 New Technology Group 8 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family describes the placement of a nonbiological device into the nervous system that monitors, assists, performs, or prevents a physiological function, without replacing any body part outright. In practice, this typically involves implanting a new-technology device, such as a specialized neurostimulator or sensing system, designed to track neurological activity or intervene in real time to manage a condition like a movement disorder or seizure activity.
These devices are distinct from earlier-generation implants because they often incorporate closed-loop or responsive functionality, meaning they can sense abnormal neurological signals and respond automatically, rather than delivering a fixed, unchanging therapy. Placement is performed surgically, frequently with imaging guidance, and the device remains in the body on an ongoing basis to support the patient's neurological function over time.
Anatomy & Axis Detail
Vagus Nerve
The vagus nerve carries extensive parasympathetic outflow to the heart, lungs, and gastrointestinal tract, and insertion of a stimulation device onto this nerve is used in emerging applications such as autonomic regulation therapy for chronic heart failure, where modulating vagal tone aims to rebalance the sympathetic-parasympathetic dysregulation that worsens cardiac function, as well as in certain refractory epilepsy protocols using newer lead or generator technology. The nerve runs within the carotid sheath in the neck, so device placement requires careful dissection to avoid the adjacent carotid artery, jugular vein, and recurrent laryngeal nerve. Documentation should specify laterality, since left-sided vagal stimulation is typically favored to limit cardiac side effects, and should identify the specific new-technology device to distinguish it from earlier-generation vagus nerve stimulators coded elsewhere.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Neurostimulator Lead with Paired Stimulation System
Neurostimulator Lead with Paired Stimulation System indicates that the implanted neurostimulator lead functions as part of a coordinated system with an additional paired stimulation device, enabling more advanced or synchronized neuromodulation. It reflects a more complex configuration than a standalone lead. It is distinguished from the plain Neurostimulator Lead value, which does not specify this paired-system arrangement.
Qualifier: New Technology Group 8
Group 8 identifies technologies added to the New Technology section for the 2021-2022 update cycle, tying a given code to that specific approval year. The underlying substance, device, or technique is defined by the other six axis positions, not by the group number itself. Because group numbers simply track chronology, Group 8 differs from Group 7 and Group 9 only in when CMS granted the technology separate recognition.
Coding & Documentation
A coder needs documentation naming the specific approved device inserted, since New Technology codes correspond to particular technologies rather than a general class of implants, along with the anatomical location where the device or its leads were placed. The note should make clear the device was newly inserted rather than a component of an existing device being revised or replaced, and should describe its monitoring or responsive function. A common mistake is coding a routine neurostimulator implant under this family when it does not match the specific technology tied to the New Technology code, or confusing insertion of the device with insertion of just its leads or a related component, which may carry separate documentation requirements.
Commonly Confused With
This family is frequently confused with standard Insertion codes for neurostimulators found in the Medical and Surgical section, which cover comparable devices lacking the specific approved technology designation required for a New Technology code. It also overlaps conceptually with Replacement, which applies when a device is physically taking the place of a body part rather than simply monitoring or assisting function, and with Revision, which applies to correcting or adjusting a previously placed device rather than placing a new one.